Transgenomic Inc. | Ownership
Companies that own Transgenomic Inc.
Fidelity Management & Research Co.
6,314,261
14.1%
6,314,261
0.01%
06/30/2018
The Baupost Group LLC
1,923,076
4.3%
1,923,076
0.15%
06/30/2018
Rock Springs Capital Management LP
1,011,079
2.25%
1,011,079
0.39%
06/30/2018
Bain Capital Public Equity LP
974,843
2.18%
974,843
0.64%
06/30/2018
Federated Global Investment Management Corp.
710,195
1.59%
710,195
0.05%
06/30/2018
ArrowMark Colorado Holdings LLC
689,694
1.54%
689,694
0.07%
06/30/2018
Deerfield Management Company LP
650,000
1.45%
650,000
0.2%
06/30/2018
Citigroup Global Markets, Inc. (Investment Management)
571,000
1.27%
571,000
0.02%
06/30/2018
Perceptive Advisors LLC
500,000
1.12%
500,000
0.12%
06/30/2018
Invus Public Equities Advisors LLC
500,000
1.12%
500,000
0.18%
06/30/2018
| Address |
29 Hartwell Avenue
Lexington Massachusetts 02421
United States
|
|
Employees
|
- |
| Website |
http://www.translate.bio |
| Updated |
07/08/2019 |
| Translate Bio, Inc. engages in the research and development of therapeutic drugs. Its proprietary technology to rapidly advance a pipeline of novel drugs for diverse therapeutic areas, with an initial emphasis in the fields of rare genetic disorders, inflammation, oncology, metabolic diseases and neurodegenerative diseases. The company was founded in 2011 and is headquartered in Cambridge, MA. |
